MeSH tree: E05.196.309.742.225
A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).
Aug 26, 2025
0
20
A new study from Karolinska Institutet shows how a small antibody fragment can block fertilization by targeting a key protein on the surface of the egg. This discovery brings a nonhormonal contraceptive one step closer to ...
Apr 14, 2025
0
17
Infections with the hepatitis E virus often go unnoticed because they cause no symptoms. However, in patients with a weakened immune system or existing liver damage and also in pregnant women, the virus can cause severe liver ...
Mar 12, 2025
0
18
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.
Feb 20, 2025
0
42
In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses even as they mutate, raising hopes for a longer-lasting vaccine and a universal protection against ...
Feb 10, 2025
0
37
Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses.
Dec 13, 2024
0
40
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain cells of young Parkinson's patients, ...
Sep 19, 2024
0
61
Deaths from cancer or infections can occur when available treatments are ineffective. Once turned on, pregnane X receptor (PXR) activates the expression of genes encoding enzymes that metabolize external chemicals, including ...
May 15, 2024
0
59
By studying individuals who spontaneously clear hepatitis C infections, a team of researchers has identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year.
Mar 25, 2024
0
87
Some cancerous tumors hijack proteins that act as "brakes" on our immune system and use them to form a sort of shield against immune recognition. Immunotherapy treatments have been created that turn off these "brakes" and ...
Mar 11, 2024
0
49
